DG

Dave Garman

Chief Technology Officer

NoNO Inc

Toronto, Ontario


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
NoNO Inc
Industry
biotechnology
Employees
95.0
Seniority
C suite
Annual Revenue
7000000.0

Technologies

Outlook Amazon AWS Cloudinary Google Tag Manager Mobile Friendly Vimeo Google Font API Apache WordPress.org Remote

Keywords

drug development stroke clinical trials pharmaceuticals neuroprotection neurorestoration psd-95 inhibition nerinetide acute ischemic stroke stroke therapy brain ischemia stem cell therapy neurological recovery chronic neurological conditions traumatic brain injury clot dissolving drugs phase 1 phase 3 neurodegenerative diseases stroke mortality reduction neuronal protection cerebrovascular health stroke recovery autoinjector devices clinical operations pharmacokinetics pharmaceutical innovation patient outcomes safety & tolerability therapeutic strategies research collaboration medical devices neuroscience research brain injury treatment neuroplasticity functional independence clinical efficacy medical imaging ischemia pharmaceutical research patient care global health biomedical engineering cognitive rehabilitation patient empowerment biotech company neural health clinical data analysis health care health wellness & fitness hospital & health care medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans